- Home
- VSTE vs TLSA Comparison
VSTE vs TLSA Comparison
Compare VSTE & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTE
- TLSA
- Stock Information
- Founded
- VSTE 2009
- TLSA 2013
- Country
- VSTE Australia
- TLSA United Kingdom
- Employees
- VSTE N/A
- TLSA N/A
- Industry
- VSTE
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- VSTE
- TLSA Health Care
- Exchange
- VSTE Nasdaq
- TLSA Nasdaq
- Market Cap
- VSTE 30.0M
- TLSA 87.8M
- IPO Year
- VSTE N/A
- TLSA 2000
- Fundamental
- Price
- VSTE $2.42
- TLSA $1.20
- Analyst Decision
- VSTE
- TLSA
- Analyst Count
- VSTE 0
- TLSA 0
- Target Price
- VSTE N/A
- TLSA N/A
- AVG Volume (30 Days)
- VSTE 14.1K
- TLSA 145.8K
- Earning Date
- VSTE 01-01-0001
- TLSA 05-10-2024
- Dividend Yield
- VSTE N/A
- TLSA N/A
- EPS Growth
- VSTE N/A
- TLSA N/A
- EPS
- VSTE N/A
- TLSA N/A
- Revenue
- VSTE $342,000.00
- TLSA N/A
- Revenue This Year
- VSTE N/A
- TLSA N/A
- Revenue Next Year
- VSTE N/A
- TLSA N/A
- P/E Ratio
- VSTE N/A
- TLSA N/A
- Revenue Growth
- VSTE N/A
- TLSA N/A
- 52 Week Low
- VSTE $0.83
- TLSA $0.41
- 52 Week High
- VSTE $12.00
- TLSA $1.74
- Technical
- Relative Strength Index (RSI)
- VSTE 55.09
- TLSA 65.44
- Support Level
- VSTE $0.83
- TLSA $0.83
- Resistance Level
- VSTE $1.09
- TLSA $0.92
- Average True Range (ATR)
- VSTE 0.10
- TLSA 0.09
- MACD
- VSTE 0.03
- TLSA 0.03
- Stochastic Oscillator
- VSTE 92.08
- TLSA 84.52
About VSTE Vast Renewables Limited
Vast Renewables Ltd is a clean, renewable energy company specializing in the design and manufacturing of concentrated solar thermal power (CSP) systems to generate carbon-free, utility-scale electricity, industrial heat, and green fuels. The Company's differentiated modular CSP system, utilizing proprietary sodium loop heat transfer technology, provides customers with a solution to the enduring challenge of intermittent renewable energy through 24/7 dispatchable power and heat.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.